CTMX vs. ERIC

Last updated Jun 4, 2026

CTMX (CytomX Therapeutics, Inc.) and ERIC (Telefonaktiebolaget LM Ericsson (publ)) are both stocks. CTMX operates in Biotechnology (Healthcare), while ERIC operates in Communication Equipment (Technology). Over the past 10 years, CTMX returned -11.44%/yr vs 8.27%/yr for ERIC. At a 0.23 correlation, their price movements are largely independent.

Performance

CTMX vs. ERIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CytomX Therapeutics, Inc. (CTMX) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CTMX achieves a -24.41% return, which is significantly lower than ERIC's 38.32% return. Over the past 10 years, CTMX has underperformed ERIC with an annualized return of -11.44%, while ERIC has yielded a comparatively higher 8.27% annualized return.

CTMX

• 1D: 1.90%
• 1M: -22.97%
• YTD: -24.41%
• 6M: -19.50%
• 1Y: 21.51%
• 3Y*: 23.01%
• 5Y*: -13.81%
• 10Y*: -11.44%

ERIC

• 1D: -4.22%
• 1M: 13.16%
• YTD: 38.32%
• 6M: 37.90%
• 1Y: 60.00%
• 3Y*: 41.47%
• 5Y*: 3.79%
• 10Y*: 8.27%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CTMX vs. ERIC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CTMX CytomX Therapeutics, Inc.	-24.41%	313.59%	-33.55%	-3.13%	-63.05%	-33.89%	-21.18%	-44.97%	-28.47%	92.08%
ERIC Telefonaktiebolaget LM Ericsson (publ)	38.32%	24.14%	33.36%	13.40%	-44.43%	-7.26%	38.51%	0.17%	35.45%	16.57%

Correlation

The correlation between CTMX and ERIC is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (10Y) Calculated over the trailing 10-year period	0.23
Correlation (All Time) Calculated using the full available price history since Oct 9, 2015	0.23

The correlation between CTMX and ERIC shifts across timeframes, from 0.11 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CTMX : $570.82M ERIC : $43.99B
EPS CTMX : -$0.37 ERIC : $7.42
PS Ratio CTMX : 14.53 ERIC : 0.19
PB Ratio CTMX : 1.78 ERIC : 0.43
Total Revenue (TTM) CTMX : $35.54M ERIC : $229.49B
Gross Profit (TTM) CTMX : $24.77M ERIC : $110.27B
EBITDA (TTM) CTMX : -$62.07M ERIC : $46.17B

Return for Risk

CTMX vs. ERIC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTMX

CTMX Risk / Return Rank: 52
CTMX Sharpe Ratio Rank: 49
CTMX Sortino Ratio Rank: 56
CTMX Omega Ratio Rank: 55
CTMX Calmar Ratio Rank: 50
CTMX Martin Ratio Rank: 51

ERIC

ERIC Risk / Return Rank: 85
ERIC Sharpe Ratio Rank: 84
ERIC Sortino Ratio Rank: 84
ERIC Omega Ratio Rank: 86
ERIC Calmar Ratio Rank: 86
ERIC Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CTMX vs. ERIC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CytomX Therapeutics, Inc. (CTMX) and Telefonaktiebolaget LM Ericsson (publ) (ERIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CTMX	ERIC	Difference
Sharpe ratio Return per unit of total volatility	0.22	1.73	-1.50
Sortino ratio Return per unit of downside risk	1.11	2.71	-1.60
Omega ratio Gain probability vs. loss probability	1.14	1.37	-0.23
Calmar ratio Return relative to maximum drawdown	0.41	3.82	-3.41
Martin ratio Return relative to average drawdown	0.91	9.84	-8.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CTMX vs. ERIC - Sharpe Ratio Comparison

The current CTMX Sharpe Ratio is 0.22, which is lower than the ERIC Sharpe Ratio of 1.73. The chart below compares the historical Sharpe Ratios of CTMX and ERIC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CTMX	ERIC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.22	1.73	-1.50
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.10	0.11	-0.21
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.10	0.24	-0.34
Sharpe Ratio (All Time) Calculated using the full available price history	-0.11	0.12	-0.23

Drawdowns

CTMX vs. ERIC - Drawdown Comparison

The maximum CTMX drawdown since its inception was -98.74%, roughly equal to the maximum ERIC drawdown of -98.59%. Use the drawdown chart below to compare losses from any high point for CTMX and ERIC.

Drawdown Indicators

	CTMX	ERIC	Difference
Max Drawdown Largest peak-to-trough decline	-98.74%	-98.59%	-0.15%
Max Drawdown (1Y) Largest decline over 1 year	-53.19%	-15.79%	-37.40%
Max Drawdown (3Y) Largest decline over 3 years	-91.59%	-22.61%	-68.98%
Max Drawdown (5Y) Largest decline over 5 years	-94.16%	-63.96%	-30.20%
Max Drawdown (10Y) Largest decline over 10 years	-98.74%	-66.59%	-32.15%
Current Drawdown Current decline from peak	-90.59%	-81.26%	-9.33%
Average Drawdown Average peak-to-trough decline	-70.69%	-67.76%	-2.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.71%	6.12%	+17.59%

Volatility

CTMX vs. ERIC - Volatility Comparison

CytomX Therapeutics, Inc. (CTMX) has a higher volatility of 13.80% compared to Telefonaktiebolaget LM Ericsson (publ) (ERIC) at 11.58%. This indicates that CTMX's price experiences larger fluctuations and is considered to be riskier than ERIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CTMX	ERIC	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.80%	11.58%	+2.22%
Volatility (6M) Calculated over the trailing 6-month period	68.42%	22.74%	+45.68%
Volatility (1Y) Calculated over the trailing 1-year period	96.69%	34.92%	+61.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	141.79%	34.38%	+107.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.36%	35.15%	+76.21%

Dividends

CTMX vs. ERIC - Dividend Comparison

CTMX has not paid dividends to shareholders, while ERIC's dividend yield for the trailing twelve months is around 2.38%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CTMX CytomX Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ERIC Telefonaktiebolaget LM Ericsson (publ)	2.38%	3.04%	3.22%	4.07%	4.22%	2.15%	1.36%	1.24%	1.42%	1.67%	5.14%	5.30%

Financials

Frequently Asked Questions

Can I hold both CTMX and ERIC in my portfolio?

CTMX and ERIC have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CTMX or ERIC?

CTMX has higher volatility (13.80%) compared to ERIC (11.58%). In terms of maximum drawdown, CTMX dropped -98.74% vs ERIC's -98.59%.

Which has better risk-adjusted returns?

ERIC currently has the higher Sharpe Ratio (1.73 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.